====== 2-Methoxyestradiol 0.55 to 1μM on day4 R07 exp312 ======
==== Mechanism of Action ====
Endogenous estradiol metabolite, weak agonist for estrogen receptor, agonist of GPER1, microtubule destabilizer
* **Class / Subclass 1:** Metabolism / Metabolite
* **Class / Subclass 2:** Signal Transduction / GPCR Agonist
* **Class / Subclass 3:** Cell Cycle / Microtubule Poison
==== Technical Notes ====
* **PubChem Name:** %%2-Methoxyestradiol%%
* **Synonyms:** 2-ME2; NSC-659853
* **CAS #:** 362-07-2
* **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/66414|66414]]
* **IUPAC:** %%(8R,9S,13S,14S,17S)-2-methoxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol%%
* **INCHI Name:** InChI=1S/C19H26O3/c1-19-8-7-12-13(15(19)5-6-18(19)21)4-3-11-9-16(20)17(22-2)10-14(11)12/h9-10,12-13,15,18,20-21H,3-8H2,1-2H3/t12-,13+,15-,18-,19-/m0/s1
* **INCHI Key:** CQOQDQWUFQDJMK-SSTWWWIQSA-N
* **Molecular Weight:** 302.4
* **Canonical SMILES:** CC12CCC3C(C1CCC2O)CCC4=CC(=C(C=C34)OC)O
* **Isomeric SMILES:** C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=C(C=C34)OC)O
* **Molecular Formula:** C19H26O3
{{:chemogenomics:structures:chem-0021.svg?nolink}}
* **Supplier Name:** Toronto Research Chemicals
* **Catalog #:** M262625
* **Lot #:** 1-GNM-86-4
* **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C19H26O3 303.19547; found 303.19491
* **Platform ID:** Methoxy_b-Estradiol
* **Min:** -4.8666; **Max:** 98.0088
{{:chemogenomics:dose_response:dr_390.png?nolink&500 |}}
\\
\\
\\
\\
|< 300px 100px 200px >|
^ IC ^ Concentration (µM) ^
| IC10 |N/A |
| IC20 |0.1847 |
| IC30 |0.2756 |
| IC40 |0.3897 |
| IC50 |0.5415 |
| IC60 |N/A |
| IC70 |N/A |
| IC80 |N/A |
| IC90 |N/A |
\\
==== Screen Summary ====
* **Round**: 07
* **Dose**: 0.55-1µM
* **Days of incubation**: 8
* **Doublings**: 5.0
* **Numbers of reads**: 16393425
==== Screen Results ====
^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^
|4/12|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/2-Methoxyestradiol_0.55-1day4uM_Round-7_exp312.txt|Scores]]||||||
{{:chemogenomics:cranks_plots:exp312.png?nolink}}
^Gene^CRANKS Score^FDR^
|[[:human_genes:P:PDS5B|PDS5B]]|-3.08|<0.01|
|[[:human_genes:A:ASPM|ASPM]]|-3.07|0.01|
|[[:human_genes:R:RSRC2|RSRC2]]|-3.05|0.15|
|[[:human_genes:M:MSI2|MSI2]]|-2.83|0.04|
|[[:human_genes:E:ESCO2|ESCO2]]|-2.80|0.02|
|[[:human_genes:P:PSMB8|PSMB8]]|-2.58|0.05|
|[[:human_genes:C:CALM2|CALM2]]|-2.54|0.08|
|[[:human_genes:C:CNOT2|CNOT2]]|-2.51|0.06|
|[[:human_genes:R:RBM26|RBM26]]|-2.51|0.08|
|[[:human_genes:N:NPRL2|NPRL2]]|-2.45|0.07|
|[[:human_genes:D:DDX3X|DDX3X]]|-2.42|0.08|
|[[:human_genes:W:WDR26|WDR26]]|-2.40|0.14|
|[[:human_genes:K:KIF11|KIF11]]|-2.39|0.56|
|[[:human_genes:L:LRRC8A|LRRC8A]]|-2.35|0.08|
|[[:human_genes:B:BRD1|BRD1]]|-2.31|0.10|
|[[:human_genes:F:FNDC9|FNDC9]]|-2.31|0.13|
|[[:human_genes:C:CENPN|CENPN]]|-2.30|0.13|
|[[:human_genes:U:UBE2I|UBE2I]]|-2.29|0.13|
|[[:human_genes:T:TAOK3|TAOK3]]|-2.27|0.11|
|[[:human_genes:Q:QRICH1|QRICH1]]|-2.27|0.20|
|[[:human_genes:T:TMC2|TMC2]]|-2.25|0.14|
|[[:human_genes:G:GID8|GID8]]|-2.25|0.11|
|[[:human_genes:Z:ZWILCH|ZWILCH]]|-2.25|0.11|
|[[:human_genes:F:FAM122A|FAM122A]]|-2.24|0.11|
|[[:human_genes:Z:ZW10|ZW10]]|-2.20|0.13|
|[[:human_genes:S:SSR1|SSR1]]|-2.19|0.13|
|[[:human_genes:C:CWC27|CWC27]]|-2.17|0.13|
|[[:human_genes:T:TCF4|TCF4]]|-2.13|0.14|
|[[:human_genes:K:KIF18A|KIF18A]]|-2.12|0.14|
|[[:human_genes:C:CORO6|CORO6]]|-2.11|0.14|
|[[:human_genes:P:PTPMT1|PTPMT1]]|2.06|0.34|
|[[:human_genes:C:CCNF|CCNF]]|2.06|0.30|
|[[:human_genes:T:TNNC1|TNNC1]]|2.09|0.20|
|[[:human_genes:L:LARS2|LARS2]]|2.11|0.28|
|[[:human_genes:C:CAP2|CAP2]]|2.11|0.28|
|[[:human_genes:T:TRIM28|TRIM28]]|2.13|0.17|
|[[:human_genes:C:CDC5L|CDC5L]]|2.16|0.38|
|[[:human_genes:D:DEFB115|DEFB115]]|2.20|0.21|
|[[:human_genes:H:H2AFZ|H2AFZ]]|2.22|0.11|
|[[:human_genes:S:SEC14L1|SEC14L1]]|2.23|0.11|
|[[:human_genes:I:ING5|ING5]]|2.23|0.11|
|[[:human_genes:A:ATAT1|ATAT1]]|2.27|0.09|
|[[:human_genes:C:CARD16|CARD16]]|2.29|0.09|
|[[:human_genes:C:CLASP2|CLASP2]]|2.29|0.09|
|[[:human_genes:C:COPE|COPE]]|2.34|0.57|
|[[:human_genes:Z:ZNF592|ZNF592]]|2.34|0.21|
|[[:human_genes:D:DYNC1H1|DYNC1H1]]|2.35|0.47|
|[[:human_genes:A:ARHGAP11B|ARHGAP11B]]|2.39|0.06|
|[[:human_genes:N:NDE1|NDE1]]|2.43|0.05|
|[[:human_genes:S:SLC25A51|SLC25A51]]|2.46|0.05|
|[[:human_genes:A:AMBRA1|AMBRA1]]|2.46|0.05|
|[[:human_genes:T:TP53|TP53]]|2.71|0.04|
|[[:human_genes:N:NUMA1|NUMA1]]|2.76|0.03|
|[[:human_genes:A:AFF1|AFF1]]|2.77|0.05|
|[[:human_genes:K:KIF18B|KIF18B]]|2.89|<0.01|
|[[:human_genes:P:PPP2R1A|PPP2R1A]]|3.22|<0.01|
|[[:human_genes:A:ATP1A1|ATP1A1]]|3.41|<0.01|
|[[:human_genes:S:SETDB1|SETDB1]]|3.48|<0.01|
|[[:human_genes:T:TIPRL|TIPRL]]|3.65|<0.01|
|[[:human_genes:L:LCMT1|LCMT1]]|5.04|<0.01|
^Screen^Correlation^Plot^
|[[:results:exp460|BML-284 0.09μM R08 exp460]]|0.137||
|[[:results:exp59|UMK57 1μM R01 exp59]]|0.13||
|[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|0.123||
|[[:results:exp217|Mdivi-1 15μM R05 exp217]]|0.121||
|[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|0.108||
|[[:results:exp310|2-Methoxyestradiol 0.55μM R07 exp310]]|0.105||
|[[:results:exp517|Quercetin 20μM R08 exp517]]|0.101||
|[[:results:exp190|Vincristine 0.0005μM R04 exp190]]|0.087||
|[[:results:exp67|BVD-523 15μM R02 exp67]]|0.084||
|[[:results:exp106|UM131593 0.2μM R03 exp106]]|0.084||
|[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|0.078||
|[[:results:exp215|Colchicine 0.009μM R05 exp215]]|0.076||
|[[:results:exp107|UMK57 0.6μM R03 exp107]]|0.067||
|[[:results:exp360|Genistein 15μM R07 exp360]]|0.067||
|[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|0.063||
|[[:results:exp175|3-Bromopyruvate 7μM R04 exp175]]|0.062||
|[[:results:exp162|BI-D1870 2μM R04 exp162]]|0.06||
|[[:results:exp359|FK-506 30μM R07 exp359]]|0.058||
|[[:results:exp290|LLY-283 2.6μM R06 exp290]]|0.058||
|[[:results:exp502|Milciclib 2μM R08 exp502]]|0.057||
|[[:results:exp356|Docosahexaenoic-acid 50μM R07 exp356]]|0.055||
|[[:results:exp128|GSK591 2.6μM R03 exp128]]|0.054||
|[[:results:exp46|HMS-I1 1μM R01 exp46]]|0.053||
|[[:results:exp354|Diepoxybutane 3μM R07 exp354]]|0.052||
|[[:results:exp78|Pterostilbene 16μM R02 exp78]]|0.052||
|[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|0.051||
|[[:results:exp294|Nutlin-3A 1.6μM R06 exp294]]|0.051||
|[[:results:exp311|2-Methoxyestradiol 0.55 to 0.75μM on day4 R07 exp311]]|0.172||
{{:chemogenomics:comparison_plots:exp312_vs_exp460.png?nolink |}}
{{:chemogenomics:comparison_plots:exp312_vs_exp59.png?nolink |}}
{{:chemogenomics:comparison_plots:exp228_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp217_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp179_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp310_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp312_vs_exp517.png?nolink |}}
{{:chemogenomics:comparison_plots:exp190_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp312_vs_exp67.png?nolink |}}
{{:chemogenomics:comparison_plots:exp106_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp312_vs_exp60.png?nolink |}}
{{:chemogenomics:comparison_plots:exp215_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp107_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp312_vs_exp360.png?nolink |}}
{{:chemogenomics:comparison_plots:exp184_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp175_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp162_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp312_vs_exp359.png?nolink |}}
{{:chemogenomics:comparison_plots:exp290_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp312_vs_exp502.png?nolink |}}
{{:chemogenomics:comparison_plots:exp312_vs_exp356.png?nolink |}}
{{:chemogenomics:comparison_plots:exp128_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp312_vs_exp46.png?nolink |}}
{{:chemogenomics:comparison_plots:exp312_vs_exp354.png?nolink |}}
{{:chemogenomics:comparison_plots:exp312_vs_exp78.png?nolink |}}
{{:chemogenomics:comparison_plots:exp227_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp294_vs_exp312.png?nolink |}}
{{:chemogenomics:comparison_plots:exp311_vs_exp312.png?nolink |}}
^GO Term^Fold Change^Genes^
|RZZ complex|637.65|ZWILCH,ZW10|
|kinetochore microtubule|106.28|ZWILCH,ZW10,KIF18A|
|spindle microtubule|41.41|CALM2,KIF11,ZWILCH,ZW10,KIF18A|
|chromosome, centromeric region|16.35|PDS5B,ESCO2,CENPN,ZWILCH,ZW10,KIF18A|
|chromosome segregation|13.69|ASPM,ESCO2,DDX3X,KIF11,CENPN,ZW10,KIF18A|
|chromosomal region|10.28|PDS5B,ESCO2,CENPN,ZWILCH,ZW10,KIF18A|
|chromosome organization|10.14|PDS5B,ESCO2,DDX3X,KIF11,CENPN,ZW10,KIF18A|
|cell cycle process|8.78|PDS5B,ASPM,ESCO2,CALM2,DDX3X,KIF11,CENPN,UBE2I,TAOK3,ZWILCH,ZW10,KIF18A|
|mitotic cell cycle process|8.65|CALM2,KIF11,UBE2I,TAOK3,ZWILCH,ZW10,KIF18A|
|mitotic cell cycle|7.44|CALM2,KIF11,UBE2I,TAOK3,ZWILCH,ZW10,KIF18A|
^GO Term^Fold Change^Genes^
|establishment of spindle localization|40.94|NUMA1,NDE1,DYNC1H1,CLASP2|
|spindle localization|37.47|NUMA1,NDE1,DYNC1H1,CLASP2|
|cytoplasmic microtubule|26.32|KIF18B,NUMA1,DYNC1H1,CLASP2|
|mitotic cell cycle process|9.64|LCMT1,PPP2R1A,KIF18B,NUMA1,TP53,NDE1,DYNC1H1,CLASP2,CCNF|
|positive regulation of cellular component biogenesis|8.95|SETDB1,NUMA1,TP53,AMBRA1,DYNC1H1,CLASP2,ATAT1,TRIM28|
|mitotic cell cycle|8.29|LCMT1,PPP2R1A,KIF18B,NUMA1,TP53,NDE1,DYNC1H1,CLASP2,CCNF|
|regulation of cell cycle process|7.19|LCMT1,TIPRL,PPP2R1A,NUMA1,TP53,AMBRA1,DYNC1H1,CDC5L,CCNF|
|cell cycle process|5.70|LCMT1,PPP2R1A,KIF18B,NUMA1,TP53,NDE1,DYNC1H1,CLASP2,CCNF|